The British National Formulary (BNF) provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines. This essential reference reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.
BNF 65 (March 2013) has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. Access to the latest edition of the BNF is vital for healthcare professionals, as there are a large number of updates from one edition to the next.
Some of the significant changes in this edition include:
• Updated guidance on pain management in palliative care • Updated advice on the management of hereditary angioedema • Revised guidance on the treatment of endocarditis • Updated advice on the risk of malignancy with long-term use of calcitonin
The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee.